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Abstract
Cardiovascular diseases pose a significant medical problem in the developed world. Coronary
heart disease (CHD) is the most common of these and is the cause of more than half the cases of
heart failure in the general population below 75 years of age. Atherosclerosis lies at the basis of
the majority of CHD cases. As the early detection of asymptomatic CHD may lower patient
morbidity and mortality, there is an ongoing search for non-invasive diagnostic techniques.
Computed tomography, which enables coronary artery calcification to be assessed, is one of
these. Examples of the implementation of a calcium score, both in asymptomatic patients and in
patients with diagnosed CHD, are presented in this paper. (Folia Cardiol. 2006; 13: 459–464)
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Introduction
In view of their prevalence and related costs,
cardiovascular diseases pose a significant medical
problem in the developed world. Coronary heart
disease (CHD) is the most common of them and is
the cause of more than half the cases of heart failure
in the general population below the age of 75 [1, 2].
Cardiovascular diseases do not predominate as
a cause of death until the age of 45 in males and
65 among females. In 2001, 173 809 people died of
cardiovascular diseases in Poland and the main
cause of these deaths was coronary heart disease,
including myocardial infarction, totalling 53 800 and
28 100 deaths respectively, which amounted to 31%
and 16% of deaths from all circulatory causes [3].
In more than 85% of cases atherosclerosis lies
at the basis of CHD, an inflammatory-degenerative
process which takes place in the internal membrane
of the large and medium-caliber arteries and is re-
sponsible for the formation of atherosclerotic
plaques in the vessel lumen. Coronary artery calci-
fication can already be detected in 10–20-year olds.
The deposition of hydroxyapatite is responsible for
the calcification process. So far it has been believed
that calcium accumulations are the result of the
degenerative process, but the latest research indi-
cates that an active process, perhaps a reaction to
injury, may be responsible for their creation [4].
In 1995 the American Heart Association pro-
posed a macroscopic assessment of atherosclerot-
ic plaques, on the basis of which they were divided
into early plaques (type I–III), observed in early
childhood, distinguished from reversible and com-
plex plaques (type IV–V), characterised by progres-
sive capsule fibrosis and calcification. A complication
of these plaques may be the erosion of the membrane
covering the plaque and its rupture (type VI), which
is responsible for the occurrence of acute coronary
syndrome [5].
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Because early CHD detection in asymptomatic
patients may lower the morbidity and mortality aris-
ing from the condition, new non-invasive diagnos-
tic methods are sought. One of these methods is
computed tomography (CT) on the basis of the prop-
erties of calcium, which, with its high atomic num-
ber, absorbs X-ray radiation. As a result of this, cal-
cified lesions show up as white on CT scans and are
easily distinguished from the surrounding soft tis-
sues so that contrast administration is not required
in the examination.
At present two different CT methods are used:
electron-beam computed tomography (EBCT) and
classical CT. The first research on coronary artery
calcification was possible because of the develop-
ment of EBCT in the late 1980s. Because the speed
of these devices was much higher than that of ex-
isting devices, there was the option of “stopping”
the heart motion in order to assess coronary artery
calcification [6, 7].
In this machine, all mechanical motion was
eliminated and the beam created in the so-called
electron section diverted by the magnetic field and
directed to one of four tungsten anodes in the form
of a ring. The whole circuit runs in a high vacuum.
X-ray radiation is emitted from the anode and, af-
ter passing through the patient, is recorded in one
of two detector circuits.
As a result of EBCT it is even possible to de-
tect plaques calcified in 10–20%, which is not pos-
sible using standard diagnostic tests [6].
Three-dimensional images can be obtained from
step-volume scanning, which uses two-dimensional
images and continuous volume. Two-dimensional
scanning, ECG signal-gated, is the most common-
ly used method. The collection of data usually takes
place during diastole in order to reduce artefacts cre-
ated as a result of heart motion. Images are obtained
from 3 mm slices for the detection of calcium in the
coronary arteries. The whole heart is depicted dur-
ing one or two breaths of the patient.
Computed tomography in heart imaging be-
came more widely used after the introduction of
multi-slice computer tomography (MSCT). In these
machines an X-ray is emitted by a tube rotating
around the patient. Heart imaging can be performed
both through sequential scanning (as in step-volume
scanning in EBCT) or spiral scanning (as in contin-
uous-volume scanning in EBCT). Both types of data
collection can be ECG signal-gated, although the
lower rotation velocity of the lamp around the pa-
tient, in contrast to EBCT, requires at least 250 ms
in modern machines. For the detection of coronary
artery calcifications the slice thickness oscillates
between 1.25 and 3 mm. The whole heart can be
depicted during one breath of the patient [7].
Assessment of coronary
artery calcification
In coronary artery assessment, both in the
EBCT method and in MSCT, various algorithms are
employed. The most popular is the Agatston score,
introduced in the late 1990s to assess coronary ar-
tery calcifications in EBCT [8].
The Agatston score is based on a maximal
X-ray absorption factor measured in Hounsfield
units (HU) and the measurement of calcium accu-
mulation size. On the basis of histological research
the structure is recognised as calcified if it absorbs
130 HU or more [9]. Each coronary artery is evalu-
ated and the results obtained are summarised to re-
ceive a coronary calcium score.
The limitation of this method is the inability of
EBCT to image a single calcification while show-
ing total a calcium score (CS). This means that two
or three single 30% stenotic lesions are shown as
one 70–80% stenosis.
Alternative methods of calcification evaluation
are as follows:
— volume scoring (VS) — as in the Agatston score,
130 HU is the detection threshold; the volume
score equals the voxel number (three-dimen-
sional pixel equivalent) and single-voxel volume
product. The total VS is the sum of the individ-
ual results obtained in the examination.
— mass scoring (MS) — coronary artery calcifi-
cation assessment based on the calculation of
total calcification mass, the sum of individual
calcification masses in the arteries. This test
requires what is known as calibration factor
calculation, taking into consideration the densi-
ty of the hydroxyapatite which builds the calcifi-
cation. Because the CT number of all materials,
except for water, is dependent on the X-ray spec-
trum, calibration factors are taken into consid-
eration in every CT machine and in every re-
search protocol. MS is given in milligrams. Ini-
tial research has demonstrated that the results
obtained in this way are more reproducible than
those obtained from the Agatston score, but the
method requires further research [10].
As a result of CT (EBCT and MSCT) it is pos-
sible to evaluate not only the prevalence but also
the density of atherosclerotic plaques. This is cru-
cial, since calcified plaques are considered to be
stable. On the basis of previous research it is
assumed that soft atherosclerotic plaque has an X-ray
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absorption factor below 50 HU, that fibrous plaque
has a factor of 50–130 HU, that fibrous-calcified
plaque has a factor of 130–300 HU and that massive
calcifications have a factor of over 300 HU [11, 12].
Research comparing the calcification scores ob-
tained from EBCT and MSCT has demonstrated
a close correlation, particularly with values over 11 [13].
Calcium score application
Guidelines suggest that CHD prevention in the
elderly should be based on the evaluation and mod-
ification of possible risk factors. For this purpose
well-documented risk factor evaluation is used on
the basis of the Framingham trial, in which a corre-
spondence was demonstrated between CHD mor-
bidity and mortality and environmental and intrac-
orporal, modifiable and non-modifiable factors which
influence the progress and course of CHD [14].
Autopsies on patients who had died from acute
myocardial infarction or sudden cardiac death
proved that the intensity of atherosclerosis is
a more important factor than the degree of steno-
sis [15]. After the introduction of EBCT and the
opportunity of CS assessment, therefore, numer-
ous trials were performed to evaluate the prog-
nostic value of the coronary artery CS and its
possible application as an accessory factor which
would improve CHD risk evaluation according to
the Framingham scale [16–18].
The basic assumption that the higher CS, the
greater the probability of the existence of coronary
artery lesions was confirmed in the very first trial [8].
In the trial performed by Rumberger et al. [16]
a CS above 371 had a specificity of 90% in detect-
ing artery lumen stenosis above 70%. Specificity de-
creases with patient age and increases with the
number of affected vessels and total CS. Patient
prognosis worsened with an increase in CS. It was
demonstrated that the degree of coronary artery
calcification was a good prognostic factor of the
progress of symptomatic coronary heart disease.
Guerci et al. [17] performed angiography in
asymptomatic patients with elevated CS values. Not
only elevated CS values (average 573 ± 504) but
also coronary arteries stenotic lesions (with an
average stenosis of 45% ± 16%) were shown in
these patients. Average artery stenosis was depen-
dent on CS elevation in all patients.
Behrenbeck et al. [18] showed that in per-
sons with a low or moderate CHD risk CS evalu-
ation is more economically reasonable than per-
forming a stress test, perfusion scintigraphy or
stress echo.
In the trial by Detrano et al. [19], the Framing-
ham scale and EBCT were of similar efficacy in
detecting CHD risk in asymptomatic patients. It was
also demonstrated that a tomographic CS increas-
es in proportion to the number of traditional risk
factors. Hoff et al. [20] showed in a group of 30 908
healthy people (men and women) a statistical cor-
respondence between elevated CS values and cig-
arette smoking, hypercholesterolaemia, diabetes
and arterial hypertension. Unfortunately, although
typical risk factor assessment enables most coro-
nary events to be predicted, they also occur in peo-
ple without typical risk factors and with low calci-
um scores [20].
Although the Framingham study [14] and the
Multiple Risk Intervention Trial [21] demonstrat-
ed the relationship between cholesterol level and
mortality from CHD, a quarter of deaths still occur
in patients with a cholesterol level of around 182–
–244 mg% [21]. In these cases it is suggested that
the cause of death could be plaques which do not
occlude the vessel lumen.
In an autopsy trial Taylor et al. [22] compared
the Framingham risk factors, the extent of calcifi-
cation and histological features of atherosclerotic
plaques in individuals who had died from sudden
cardiac death. In the majority of cases (50 out of 79)
the extent of plaque calcification was related to the
Framingham risk score. In other cases, amounting
to about 25%, atherosclerotic plaque erosion result-
ing in thrombus formation was the cause of death.
These patients had both a significantly lower CS and
lower Framingham index values.
Following on from this, despite numerous re-
ports on the rationale of CS assessment, a document
published in June 2000 by the American College of
Cardiology (ACC) and the American Heart Associ-
ation (AHA) in the Journal of the American College
of Cardiology summarising AHA opinion regarding
CS evaluation found no grounds for a wider use of
EBCT in screening tests for CHD in asymptomatic
patients [6].
In recent years, further research has been un-
dertaken to determine the probability of CHD oc-
currence in different groups of patients (those with
undiagnosed chest pain, those who have undergone
PCI and those with modifiable CHD risk factors) or
in an attempt to employ EBCT for the evaluation of
atherosclerotic plaque progression and regression.
Moser et al. [23], on the basis of examination
of 794 asymptomatic patients, found that the great-
est benefit from CS evaluation concerns patients
with three or more CHD risk factors, because CS
values observed in them correlates with medium
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and extensive coronary artery calcifications (Agat-
ston score = 101–400), while only 41% of these
patients showed an abnormal SPECT test result.
This finding can be explained by the fact that perfu-
sion scintigraphy detects stress-induced ischaemia
but not atherosclerotic plaques. The authors sug-
gested that myocardial SPECT evaluation should
not be made before CS level reaches 400.
2003 saw the conclusion of a CHD prevention
trial, the St. Francis Heart Study [24], which includ-
ed 5585 patients (with an average age of 59, 30% of
them female) without a history of CHD or signs of
coronary vessel atherosclerosis. In all the patients
evaluated EBCT was performed to assess the ex-
tent of calcification. The Agatston scale was used.
During a 4.5-year follow-up at least one atheroscle-
rotic event (non-fatal myocardial infarction, coro-
nary related death, CABG, PTCA, ischaemic stroke,
peripheral vessel surgery) occurred in 122 patients.
It was shown that CS obtained from EBCT enabled
an independent and more precise prediction to be
made of coronary events than did standard coronary
artery disease risk factors, particularly in moder-
ate and high-risk groups according to the Framing-
ham criteria. Furthermore, it was demonstrated that
according to CS individuals at moderate risk of CHD
were present in low-risk groups as well as in high-
risk groups according to the Framingham study.
The authors have suggested that there is an argu-
ment for adding an EBCT examination for the eval-
uation of CS to risk-factor assessment in men and
women between the ages of 50 and 70 at moderate
risk of CHD.
It was shown in this trial that the prevalence
of coronary events gradually increased along with
an increase in calcium score. Participants in whom
a coronary event occurred during the trial had
a calcium score which was four times higher at the
beginning of the trial. The event frequency after
4.3 years of follow-up in participants with a calcium
score of zero was 0.5%, whereas it was 14.1% for
those with a score above 600 (p < 0.0001).
On the basis of CS results researchers have
also put forward diagnostic and therapeutic recom-
mendations. Where the CS fell within the 100 to 200
range and the frequency of coronary events was at
least 2% during one year the researchers suggest-
ed primary prevention of atherosclerotic plaques,
for example by daily aspirin administration. Where
CS ranged from 200 to 400, it was proposed to add
hypolipidaemic treatment. Patients who are asymp-
tomatic but with high calcium scores (between
200 and 400) in whom numerous disseminated but
not lumen-occluding atherosclerotic lesions are
found should undergo diagnostic stress tests, which
may reveal possible silent ischaemia. However, the
authors did not suggest routine haemodynamic
examination after EBCT in asymptomatic patients.
Calcium score evaluation can be used to predict
the natural history of atherosclerosis. Schermund
et al. [25] assessed the tomographic CS in 330 pa-
tients who had undergone EBCT for CHD symptoms
in the previous three months and who had been per-
sonally referred for EBCT because of the risk of CHD
being present. It was shown that in patients with
coronary artery disease and a lower CS the most fre-
quently affected vessel was the left anterior descend-
ing artery (54% of the patients) followed by the right
coronary artery (25% of the patients).
Left main involvement was found in 10 out of
139 patients (7%) with single and double-vessel
disease and in 17 out of 77 patients (23%) with tri-
ple-vessel disease. Most frequently calcification
was found in the proximal segment of the left ante-
rior descending artery and then in the proximal
segment of the circumflex artery and the right coro-
nary artery. Moreover, whereas in the right coronary
artery calcifications were located symmetrically, in
the left coronary artery there was a tendency for the
development of calcifications in the proximal segment,
especially in the left anterior descending artery.
Calcium score evaluation may serve for the
assessment of lesion dynamics in patients with sta-
ble coronary heart disease. Examination of 388 pa-
tients performed with multi-slice CT showed that
where there was stable coronary heart disease
there was a significant progression of lesions in the
coronary arteries in follow-up four years and more
after the first evaluation.
Cigarette smoking and entry tomographic CS
were independent prognostic factors in this trial and
the presence of new lesions in the coronary artery
wall was found in 56% of subjects [26].
Furthermore, it was found in the PREDICT
Study that in CS evaluation of type 2 diabetics the
extent of coronary artery calcifications was closely
dependent on waist-hips ratio, systolic blood pres-
sure and male gender, a finding which may be re-
lated to the prevalence of the metabolic syndrome
in these subjects [27].
Calcium score evaluation can also be useful in
monitoring the results of therapy. Budoff et al. [28]
evaluated the efficacy of hypolipidaemic treatment
with statins in 299 subjects who were treated for
basic conditions such as arterial hypertension, hy-
perlipidaemia and diabetes. EBCT was performed
before the initiation of treatment and after at least
12 months of therapy. In the group treated with
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statins a 61% slow-down in CS progression was
observed, and of 60 patients treated with statin
monotherapy 37% showed a decrease in CS was
compared to the entry result.
Calcium score assessment may gain signifi-
cance in cardiological diagnostics because it allows
data to be obtained that is different from that ac-
quired by the non-invasive methods that have been
used so far in patients at risk of CHD. It has been
said that the main advantage of EBCT is its poten-
tial as a screening test to uncover CHD in young
asymptomatic subjects with one or more CHD risk
factors. EBCT is of limited value in elderly subjects,
in whom calcifications frequently occur (for exam-
ple in patients with chronic renal failure). In view
of this, the detection of calcifications may not be
synonymous with CHD prevalence [29].
The main limitation of this method is still ac-
cess to technologically advanced CT machines,
which so far makes it impossible to apply it in Pol-
ish conditions.
Recommendations are given in Table 1 which
summarise the use of CS for CHD risk evaluation
in asymptomatic patients [30].
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